- Home
- RPRX vs DT Comparison
RPRX vs DT Comparison
Compare RPRX & DT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- DT
- Stock Information
- Founded
- RPRX 1996
- DT 2005
- Country
- RPRX United States
- DT United States
- Employees
- RPRX N/A
- DT N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- DT Computer Software: Prepackaged Software
- Sector
- RPRX Health Care
- DT Technology
- Exchange
- RPRX Nasdaq
- DT Nasdaq
- Market Cap
- RPRX 14.2B
- DT 14.8B
- IPO Year
- RPRX 2020
- DT 2019
- Fundamental
- Price
- RPRX $31.28
- DT $48.37
- Analyst Decision
- RPRX Strong Buy
- DT Buy
- Analyst Count
- RPRX 5
- DT 25
- Target Price
- RPRX $41.60
- DT $61.39
- AVG Volume (30 Days)
- RPRX 4.5M
- DT 2.8M
- Earning Date
- RPRX 05-08-2025
- DT 05-14-2025
- Dividend Yield
- RPRX 2.81%
- DT N/A
- EPS Growth
- RPRX N/A
- DT 143.79
- EPS
- RPRX 1.91
- DT 1.60
- Revenue
- RPRX $2,263,576,000.00
- DT $1,634,366,000.00
- Revenue This Year
- RPRX $34.04
- DT $21.56
- Revenue Next Year
- RPRX $6.10
- DT $15.07
- P/E Ratio
- RPRX $16.36
- DT $30.21
- Revenue Growth
- RPRX N/A
- DT 19.81
- 52 Week Low
- RPRX $24.05
- DT $39.42
- 52 Week High
- RPRX $34.20
- DT $63.00
- Technical
- Relative Strength Index (RSI)
- RPRX 35.96
- DT 37.82
- Support Level
- RPRX $30.64
- DT $46.09
- Resistance Level
- RPRX $31.51
- DT $51.53
- Average True Range (ATR)
- RPRX 0.74
- DT 1.31
- MACD
- RPRX -0.31
- DT 0.06
- Stochastic Oscillator
- RPRX 18.29
- DT 41.91
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.